It was reported that this patient suffered a syncopal episode, and a review of this event was requested.Technical services reviewed the data and discussed that detection and therapy delivery indicate appropriate device behavior based on design and programming.The mentioned syncope was due to a ventricular arrhythmia.In addition, ts recommended to shorten the duration for ventricular fibrillation zone to 1 second.Anti-tachycardia pacing (atp) was not delivered as rate was measured over 250 bpm.It appears that the appropriate delivered shock initiated an episode of atrial fibrillation.This cardiac resynchronization therapy defibrillator remains in service and no additional adverse patient effects were reported.
|